🔬Dynamics of immune responses to pathogens and tumors. 📍San Raffaele Scientific Institute & University, Milan @SanRaffaeleMI @MyUniSR

Milan, Lombardy
Joined March 2011
Hot off the press in @SciImmunology: why COVID-19 hits older hosts harder. shorturl.at/kedsb Aged platelets release more serotonin → procoagulant platelets → fibrin in the lung → respiratory failure. 1/2
5
5
30
1,200
Scientists with @DavideMarotta18 at @MyUniSR found that platelet-derived serotonin promotes blood clotting and lung dysfunction during #SARSCoV2 infection, helping explain greater disease severity with age. 🩸 🔬 bit.ly/4hdgEst Tune into the discussion: bit.ly/3VE92Ik
2
2
6
468
Delighted to share new work published in @ScienceMagazine entitled 'Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species,' led by @XanWesolowski in the lab science.org/eprint/YQNFAHKNF…
9
31
2
113
6,280
Blocking serotonin uptake or 5-HT2A protects, with no cost to viral control. Kudos to postdoc @DavideMarotta18, who spearheaded this, and to @MarcoDegiov89 for co-supervising - a genuinely fun collaboration between our two labs at @SanRaffaeleMI @MyUniSR 2/2
1
194
The immune system does not behave in the same way in every tissue. The first UniSR – @Tsinghua_Uni symposium explored new perspectives on cancer immunotherapy, neuroimmune interactions and immune memory. 👉Read more: blog.unisr.it/en/immunology-… #UniSR #Immunology @iannaconelab
2
3
304
🔬 Recruiting a Physician Scientist PhD student (San Raffaele, Milan) via AIRC-Cariplo-SEMM-UniMi program. Project: reprogramming tumor endothelium to restore anti-tumor immunity in liver cancer. Keep 20% clinical work. Deadline Sept 16. Apply: tinyurl.com/3vcp27dp #AIRC
2
1
6
1,910
Fascinating work from the @IdoAmitLab! A must read
1/15 Can we engineer safer, more effective CAR T cells for MS? New in @CellCellPress: we identify pathogenic PD-1⁺ T cells and target them with inflammation-gated CAR T cells that reprogram neuroinflammation. @Rotem_Shalita @mayaby15 Chamutal Gur cell.com/cell/fulltext/S0092…
1
13
1,349
Great science and fun at our lab's annual retreat, bringing together my team with Mirela Kuka, @MarcoDegiov89, and Donato Inverso's teams. Thanks to invited speakers @Lo_Zanzi and Stefano Sammicheli for inspiring lectures and great questions. Proud of what we've built together.
1
1
1
8
1,766
In vista della Giornata Mondiale dell'Epatite (28 luglio), abbiamo raccontato a UniSR le due strategie complementari su cui lavoriamo per la cura funzionale dell'epatite B cronica 🔗 blog.unisr.it/cura-funzional…
2
283
Proud of Dr. @ValentinaVenzin, a former PhD student in my lab, for winning the EFIS ACTERIA Doctoral Thesis Prize! Her work revealed how CD4+ T cells rescue dysfunctional CD8+ T cells in the liver during chronic HBV via IL-27. Congrats, Valentina! 🎉 efis.org/news/the-fondation-…
1
1
1
15
1,220
Exciting news!👉LiveRNA, co-founded by @iannaconelab, has received the Paris-Saclay Cancer Cluster BOOST Grant to advance its next-generation #mRNA #immunotherapy platform and bring innovative cancer treatments closer to patients.
1
4
361
Iannacone Lab retweeted
Review @NatRevImmunol @Kubes_Lab @FGinhoux @iannaconelab Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers nature.com/articles/s41577-0…
10
31
1,651
Great fun to write this review on Kupffer cells with @FGinhoux and @Kubes_Lab, covering origin, diversity and roles in immunity and metabolism, now out @NatRevImmunol. Huge credit to Bruna Araujo David, @frarro1 and Camille Blériot for driving this work. rdcu.be/fckoZ
3
1
12
885
Abortive infection: T cells as early, antibody-independent defenders dlvr.it/TRrTjj
25
80
5,255
Neutralizing antibodies are not the whole story. In @NatRevImmunol, we highlight an alternative mode of protection: T cells can eliminate infection at its earliest stage, before it becomes detectable. We term this “abortive infection” rdcu.be/fbq8p Thread 1/4
2
15
4
46
6,035
Implications: • T cells can act at inception, not just during clearance • Standard readouts (serology/PCR) miss these events • True exposure and immunity are likely underestimated → We need to measure what T cells actually do
1
1
10
500
This calls for a shift in vaccine design: • target early, conserved viral proteins • build tissue-resident immunity • combine antibodies and T cells Great collaboration with Leo Swadling, @ValeFuma91 and @maini_lab
2
6
285